Income Statement Laboratorios Richmond S.A.C.I.F.

Stocks

RICH

ARLRIC300027

Pharmaceuticals

End-of-day quote Buenos Aires S.E. 28/09/2026			5-day change	1st Jan Change
1,440.00 ^ARS	-4.64%		-7.69%	-27.09%

06/08	Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
11/05	Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026	CI

0996992c5d7e68.rY1imCXaZWcn-KYk9H5ttIKDu5MhkzmVN01MQUeejUo.49hQ-xOwPxETnvQSgw4E3sPO7OVM6grFeHR6In7m0n_eyzioapkBDXCB4w

Published financial data: LABORATORIOS RICHMOND S.A.C.I.F.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (ARS)	2022 (ARS)	2023 (ARS)	2024 (ARS)	2025 (ARS)
Revenues	1.66TCr	1.85TCr	3.9TCr	9.18TCr	13TCr
Total Revenues	1.66TCr	1.85TCr	3.9TCr	9.18TCr	13TCr
Cost of Goods Sold, Total	1.16TCr	961.06Cr	1.87TCr	4.16TCr	4.83TCr
Gross Profit	503.88Cr	885.96Cr	2.03TCr	5.02TCr	7.85TCr
Selling General & Admin Expenses, Total	252.42Cr	553Cr	1.5TCr	3.3TCr	4.68TCr
Other Operating Expenses	19Cr	35Cr	-	169.83Cr	171.44Cr
Other Operating Expenses, Total	271.64Cr	587.73Cr	1.5TCr	3.47TCr	4.85TCr
Operating Income	232.24Cr	298.24Cr	529.89Cr	1.56TCr	2.99TCr
Interest Expense, Total	-74Cr	-143.08Cr	-530.84Cr	-328.79Cr	-1.5TCr
Interest And Investment Income	-	-	-	720.33Cr	-
Net Interest Expenses	-74Cr	-143.08Cr	-530.84Cr	391.54Cr	-1.5TCr
Income (Loss) On Equity Invest.	-	23.55L	-38.55L	-38Cr	-6.34Cr
Currency Exchange Gains (Loss)	-92Cr	-294.13Cr	-2.53TCr	-873.06Cr	-1.31TCr
Other Non Operating Income (Expenses)	3.13Cr	187.14Cr	1.49TCr	2.06TCr	1.34TCr
EBT, Excl. Unusual Items	69Cr	48Cr	-1.04TCr	3.1TCr	1.52TCr
Impairment of Goodwill	-	-	-24Cr	-182.82Cr	-
Gain (Loss) On Sale Of Investments	74Cr	33Cr	-328.23Cr	-	-691.13Cr
Gain (Loss) On Sale Of Assets	33.15L	26.31L	-	-	-
Legal Settlements	-1.65Cr	-1.44Cr	-	-57Cr	-23Cr
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	141.74Cr	80Cr	-1.39TCr	2.86TCr	810.47Cr
Income Tax Expense	82Cr	64Cr	-299.75Cr	476.81Cr	596.51Cr
Earnings From Continuing Operations	60Cr	16Cr	-1.09TCr	2.38TCr	213.95Cr
Earnings Of Discontinued Operations	-	-	-	-	68Cr
Net Income to Company	60Cr	16Cr	-1.09TCr	2.38TCr	282.33Cr
Minority Interest	-99.68L	40.39L	7.56Cr	3.37Cr	26Cr
Net Income - (IS)	59Cr	16Cr	-1.09TCr	2.38TCr	308.78Cr
Net Income to Common Incl Extra Items	59Cr	16Cr	-1.09TCr	2.38TCr	308.78Cr
Net Income to Common Excl. Extra Items	59Cr	16Cr	-1.09TCr	2.38TCr	240.41Cr
Per Share Items
Net EPS - Basic	7.32	2.02	-134.37	295.29	38.24
Basic EPS - Continuing Operations	7.32	2.02	-134.37	295.29	29.77
Basic Weighted Average Shares Outstanding	8.08Cr	8.09Cr	8.08Cr	8.08Cr	8.07Cr
Net EPS - Diluted	7.32	2.02	-134.37	295.29	38.24
Diluted EPS - Continuing Operations	7.32	2.02	-134.37	295.29	29.77
Diluted Weighted Average Shares Outstanding	8.08Cr	8.09Cr	8.08Cr	8.08Cr	8.07Cr
Normalized Basic EPS	5.24	3.79	-79.57	240.21	121.28
Normalized Diluted EPS	5.24	3.79	-79.57	240.21	121.28
Dividend Per Share	-	-	-	26.89	-
Payout Ratio	10.12	311.3	-	-	85.2
Supplemental Items
EBITDA	248.57Cr	332.64Cr	644.14Cr	1.82TCr	3.3TCr
EBITA	232.24Cr	298.24Cr	529.89Cr	1.56TCr	2.99TCr
EBIT	232.24Cr	298.24Cr	529.89Cr	1.56TCr	2.99TCr
EBITDAR	248.6Cr	-	-	-	-
Effective Tax Rate - (Ratio)	57.57	80.06	21.53	16.68	73.6
Normalized Net Income	42Cr	31Cr	-642.52Cr	1.94TCr	979.29Cr
Interest on Long-Term Debt	-	90.74L	2.41Cr	3.34Cr	6.48Cr
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	4.65Cr	8.84Cr	23Cr	-	-
Selling and Marketing Expenses	178.8Cr	425.18Cr	1.11TCr	2.48TCr	3.55TCr
General and Administrative Expenses	74Cr	127.82Cr	389.41Cr	821.76Cr	1.13TCr
Research And Development Expense From Footnotes	14Cr	31Cr	479.41Cr	363.48Cr	633.49Cr
Net Rental Expense, Total	3L	-	-	-	-
Imputed Operating Lease Interest Expense	3L	-	-	-	-
Imputed Operating Lease Depreciation	51.24T	-	-	-	-
Maintenance & Repair Expenses, Total	-	-	60Cr	100.22Cr	128.41Cr

Fiscal Period: December	2021 (ARS)	2022 (ARS)	2023 (ARS)	2024 (ARS)	2025 (ARS)
Assets
Cash And Equivalents	466.68Cr	125.59Cr	64Cr	701.72Cr	1.08TCr
Short Term Investments	250.18Cr	129.79Cr	19Cr	294.82Cr	449.93Cr
Total Cash And Short Term Investments	716.86Cr	255.37Cr	82Cr	996.54Cr	1.53TCr
Accounts Receivable, Total	353.26Cr	475.57Cr	1.13TCr	2.82TCr	5.86TCr
Other Receivables	46Cr	102.25Cr	255.41Cr	385.53Cr	416.64Cr
Notes Receivable	70.57L	3L	6L	-	-
Total Receivables	400.45Cr	577.85Cr	1.38TCr	3.2TCr	6.27TCr
Inventory	382.46Cr	517.66Cr	1.58TCr	2.54TCr	4.17TCr
Other Current Assets, Total	44Cr	53Cr	95Cr	124.05Cr	79Cr
Total Current Assets	1.54TCr	1.4TCr	3.14TCr	6.86TCr	12TCr
Gross Property Plant And Equipment	953.78Cr	2.51TCr	11TCr	18TCr	28TCr
Accumulated Depreciation	-156.17Cr	-328.89Cr	-1.1TCr	-2.55TCr	-3.71TCr
Net Property Plant And Equipment	797.61Cr	2.18TCr	10TCr	16TCr	25TCr
Long-term Investments	2.79Cr	23Cr	117.11Cr	117.03Cr	202.66Cr
Goodwill	53Cr	101.74Cr	274.94Cr	415.9Cr	569.41Cr
Other Intangibles, Total	79.64L	7.46Cr	56Cr	34Cr	55Cr
Deferred Tax Assets Long-Term	14Cr	20Cr	528.31Cr	91Cr	224.21Cr
Deferred Charges Long-Term	145.5Cr	326.11Cr	1.22TCr	2.57TCr	4.14TCr
Other Long-Term Assets, Total	12Cr	11Cr	55Cr	68Cr	158.28Cr
Total Assets	2.57TCr	4.07TCr	15TCr	26TCr	42TCr
Liabilities
Accounts Payable, Total	572.44Cr	478.67Cr	2.38TCr	2.85TCr	4.38TCr
Accrued Expenses, Total	146.13Cr	116.33Cr	268.53Cr	841.12Cr	1.22TCr
Short-term Borrowings	6.53Cr	4.67Cr	64Cr	72Cr	281.14Cr
Current Portion of Long-Term Debt	172.27Cr	281.15Cr	890.31Cr	1.76TCr	5.65TCr
Current Portion of Leases	3.78Cr	5.31Cr	13Cr	30Cr	47Cr
Current Income Taxes Payable	4.92Cr	3L	-	77Cr	217.01Cr
Other Current Liabilities	27Cr	17Cr	20Cr	54Cr	175.64Cr
Total Current Liabilities	932.62Cr	903.41Cr	3.63TCr	5.68TCr	12TCr
Long-Term Debt	954.98Cr	1.84TCr	8.42TCr	13TCr	17TCr
Long-Term Leases	11Cr	14Cr	32Cr	-	2.02TCr
Deferred Tax Liability Non Current	132.08Cr	290.18Cr	1.11TCr	1.29TCr	2.08TCr
Other Non Current Liabilities	1.23Cr	2.76Cr	8.05Cr	6.17Cr	5.78Cr
Total Liabilities	2.03TCr	3.05TCr	13TCr	19TCr	33TCr
Preferred Stock Non Redeemable	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	8.08Cr	8.08Cr	8.08Cr	8.08Cr	8.08Cr
Additional Paid In Capital	229.48Cr	447Cr	1.39TCr	3.03TCr	3.99TCr
Retained Earnings	127.87Cr	243.54Cr	-326.69Cr	1.68TCr	2.27TCr
Comprehensive Income and Other	163.94Cr	310.4Cr	1.18TCr	1.72TCr	2.89TCr
Total Common Equity	529.36Cr	1.01TCr	2.25TCr	6.43TCr	9.15TCr
Minority Interest	8.2Cr	13Cr	40Cr	105.13Cr	154.4Cr
Total Equity	537.56Cr	1.02TCr	2.3TCr	6.53TCr	9.3TCr
Total Liabilities And Equity	2.57TCr	4.07TCr	15TCr	26TCr	42TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	8.08Cr	8.08Cr	8.08Cr	8.08Cr	8.08Cr
ECS Total Common Shares Outstanding	8.08Cr	8.08Cr	8.08Cr	8.08Cr	8.08Cr
Book Value / Share	65.55	124.95	279.25	796.24	1.13T
Tangible Book Value	475.45Cr	899.82Cr	1.92TCr	5.98TCr	8.52TCr
Tangible Book Value Per Share	58.88	111.43	238.31	740.52	1.06T
Total Debt	1.15TCr	2.15TCr	9.42TCr	14TCr	25TCr
Net Debt	431.54Cr	1.89TCr	9.33TCr	13TCr	23TCr
Debt Equivalent Oper. Leases	26.55L	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	8.2Cr	13Cr	40Cr	105.13Cr	154.4Cr
Equity Method Investments, Total	-	-	34Cr	5.86Cr	17Cr
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	83Cr	179.04Cr	545.46Cr	1.28TCr	1.87TCr
Inventories - Work In Process, Total	35Cr	30Cr	146.46Cr	397.61Cr	603.07Cr
Inventories - Finished Goods, Total	291.91Cr	348.81Cr	1.01TCr	1.16TCr	2.02TCr
Land - (BS)	90Cr	187.98Cr	649.7Cr	772.53Cr	1.63TCr
Machinery, Total	178.95Cr	375.95Cr	1.29TCr	2.74TCr	17TCr
Full Time Employees	620	620	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	5.19Cr	7.97Cr	21Cr	36Cr	70Cr

Fiscal Period: December	2021 (ARS)	2022 (ARS)	2023 (ARS)	2024 (ARS)	2025 (ARS)
Net Income	59Cr	16Cr	-1.09TCr	2.38TCr	308.78Cr
Depreciation & Amortization - CF	20Cr	41Cr	127.84Cr	274.79Cr	401.69Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	46.4L
Depreciation & Amortization, Total	20Cr	41Cr	127.84Cr	274.79Cr	402.16Cr
Amortization of Deferred Charges, Total - (CF)	14Cr	32Cr	105.52Cr	452.64Cr	654.59Cr
Minority Interest in Earnings - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	13.45L	10.54L	28Cr	188.33Cr	23Cr
Provision for Credit Losses	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-23.55L	-	-	-
Provision and Write-off of Bad Debts	1.65Cr	5.62Cr	-2.22Cr	14Cr	21Cr
Other Operating Activities, Total	106.64Cr	-85Cr	-1.65TCr	-1.18TCr	-418.96Cr
Change In Accounts Receivable	-69Cr	-145.49Cr	-448.52Cr	-1.86TCr	-2.5TCr
Change In Inventories	-157.66Cr	241.03Cr	27Cr	858.28Cr	-764.79Cr
Change In Accounts Payable	326.12Cr	-389.37Cr	2.6TCr	-725.58Cr	1.49TCr
Change In Income Taxes	2.54Cr	-18Cr	-6.91Cr	144.95Cr	-148.64Cr
Change in Other Net Operating Assets	69Cr	-127Cr	61Cr	3.24Cr	1.12TCr
Cash from Operations	373.4Cr	-428.56Cr	-250.57Cr	562.26Cr	186.61Cr
Capital Expenditure	-529.71Cr	-668.84Cr	-940.38Cr	-472.47Cr	-3.78TCr
Sale of Property, Plant, and Equipment	-	-	-	-	371.62Cr
Cash Acquisitions	-94.34L	-	-	-	-
Divestitures	-	-	-	15Cr	33Cr
Sale (Purchase) of Intangible assets	-63Cr	-83Cr	-311.24Cr	-408.49Cr	-1.65TCr
Investment in Marketable and Equity Securities, Total	-13Cr	5.79Cr	-46Cr	-29Cr	-74Cr
Other Investing Activities, Total	1.94Cr	1.73Cr	42Cr	-	-
Cash from Investing	-604.5Cr	-744.41Cr	-1.26TCr	-894.51Cr	-5.1TCr
Long-Term Debt Issued, Total	919.34Cr	181.87Cr	924.93Cr	1.25TCr	5.72TCr
Total Debt Issued	919.34Cr	181.87Cr	924.93Cr	1.25TCr	5.72TCr
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-5.99Cr	-51Cr	-	-	-263.1Cr
Common & Preferred Stock Dividends Paid	-5.99Cr	-51Cr	-	-	-263.1Cr
Cash from Financing	913.35Cr	130.99Cr	924.93Cr	1.25TCr	5.45TCr
Miscellaneous Cash Flow Adjustments	-26Cr	-122.71Cr	-174.43Cr	-97Cr	-314.39Cr
Net Change in Cash	656.3Cr	-1.16TCr	-755.33Cr	817.31Cr	223.95Cr
Supplemental Items
Levered Free Cash Flow	-222.85Cr	-968.93Cr	257.95Cr	-568.57Cr	-5.28TCr
Unlevered Free Cash Flow	-176.29Cr	-879.51Cr	589.72Cr	-363.08Cr	-4.34TCr
Change In Net Working Capital	-236.81Cr	387.18Cr	-1.28TCr	1.18TCr	1.84TCr
Net Debt Issued / Repaid	919.34Cr	181.87Cr	924.93Cr	1.25TCr	5.72TCr

Fiscal Period: December	2021 (ARS)	2022 (ARS)	2023 (ARS)	2024 (ARS)	2025 (ARS)
Profitability
Return on Assets	7.51	4.11	2.35	3.26	4.9
Return on Total Capital	11.77	5.78	3.07	4.19	6.09
Return On Equity %	11.37	1.54	-39.9	41.29	2.39
Return on Common Equity	11.38	1.6	-40.21	42.05	2.73
Margin Analysis
Gross Profit Margin %	30.33	47.97	52.04	54.73	61.91
SG&A Margin	15.19	29.94	38.46	35.92	36.96
EBITDA Margin %	14.96	18.01	16.5	19.88	26.04
EBITA Margin %	13.98	16.15	13.58	16.96	23.6
EBIT Margin %	13.98	16.15	13.58	16.96	23.6
Income From Continuing Operations Margin %	3.62	0.86	-28	25.94	1.69
Net Income Margin %	3.56	0.88	-27.8	25.98	2.44
Net Avail. For Common Margin %	3.56	0.88	-27.8	25.98	1.9
Normalized Net Income Margin	2.55	1.66	-16.46	21.13	7.73
Levered Free Cash Flow Margin	-13.41	-52.46	6.61	-6.19	-41.66
Unlevered Free Cash Flow Margin	-10.61	-47.62	15.11	-3.96	-34.28
Asset Turnover
Asset Turnover	0.86	0.41	0.28	0.31	0.33
Fixed Assets Turnover	3.02	0.99	0.46	0.49	0.56
Receivables Turnover (Average Receivables)	4.24	3.17	2.99	3.48	2.65
Inventory Turnover (Average Inventory)	3.7	1.52	1.17	1.39	1.29
Short Term Liquidity
Current Ratio	1.66	1.55	0.86	1.21	1.01
Quick Ratio	1.2	0.92	0.4	0.74	0.65
Operating Cash Flow to Current Liabilities	0.4	-0.47	-0.07	0.1	0.02
Days Sales Outstanding (Average Receivables)	86.14	114.98	121.97	105.11	137.7
Days Outstanding Inventory (Average Inventory)	98.55	239.77	311.17	263.26	283.78
Average Days Payable Outstanding	130.63	396.42	383.54	451.29	262.73
Cash Conversion Cycle (Average Days)	54.05	-41.66	49.61	-82.92	158.75
Long Term Solvency
Total Debt/Equity	213.63	209.94	410.21	219.76	264.82
Total Debt / Total Capital	68.12	67.74	80.4	68.73	72.59
LT Debt/Equity	179.67	181.45	368.1	191.34	200.54
Long-Term Debt / Total Capital	57.29	58.54	72.15	59.84	54.97
Total Liabilities / Total Assets	79.08	74.91	85.18	74.88	77.86
EBIT / Interest Expense	3.12	2.08	1	4.73	2
EBITDA / Interest Expense	3.39	2.37	1.24	5.57	2.27
(EBITDA - Capex) / Interest Expense	-3.72	-2.3	-0.53	4.13	-0.26
Total Debt / EBITDA	4.55	6.31	14.31	7.84	7.26
Net Debt / EBITDA	1.71	5.56	14.19	7.3	6.81
Total Debt / (EBITDA - Capex)	-4.14	-6.52	-33.31	10.57	-63.83
Net Debt / (EBITDA - Capex)	-1.56	-5.74	-33.02	9.84	-59.86
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	78.08	-42.93	-32.15	8.01	4.95
Gross Profit, 1 Yr. Growth %	10.82	-7.73	-25.27	12.24	19.22
EBITDA, 1 Yr. Growth %	-3.79	-35.6	-44.09	9.8	11.98
EBITA, 1 Yr. Growth %	-2.79	-37.48	-48.21	12.49	15.69
EBIT, 1 Yr. Growth %	-0.26	-33.6	-42.67	34.89	50.28
Earnings From Cont. Operations, 1 Yr. Growth %	-18.01	-86.39	-2.3T	-200.07	-93.17
Net Income, 1 Yr. Growth %	-19.41	-85.81	-2.23T	-200.91	-90.16
Normalized Net Income, 1 Yr. Growth %	-41.35	-61.91	-793.41	-205.05	-33.84
Diluted EPS Before Extra, 1 Yr. Growth %	-19.47	-85.84	-2.23T	-200.91	-92.34
Accounts Receivable, 1 Yr. Growth %	-18.03	-30.89	-23.87	14.73	58.03
Inventory, 1 Yr. Growth %	57.61	-30.52	-2.01	-26.19	24.76
Net Property, Plant and Equip., 1 Yr. Growth %	162.24	40.27	48.82	-27.92	18.08
Total Assets, 1 Yr. Growth %	98.6	-18.64	22.16	-22.88	22.81
Tangible Book Value, 1 Yr. Growth %	4.74	-2.84	-31.32	42.7	8.37
Common Equity, 1 Yr. Growth %	3.74	-2.15	-28.24	30.94	8.17
Cash From Operations, 1 Yr. Growth %	-2.16T	-158.92	-81.22	-223.73	-74.77
Capital Expenditures, 1 Yr. Growth %	843.51	-35.18	-54.85	-76.93	507.97
Levered Free Cash Flow, 1 Yr. Growth %	68.6	32.15	-107.73	-69.31	291.89
Unlevered Free Cash Flow, 1 Yr. Growth %	75.34	36.89	-119.29	-46.82	454.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	77.01	40.7	9.81	26.33	22.11
Gross Profit, 2 Yr. CAGR %	39.9	39.59	45.44	35.96	32.4
EBITDA, 2 Yr. CAGR %	41.07	13.47	11.68	25.85	40.91
EBITA, 2 Yr. CAGR %	45.09	11.73	5.4	23.34	47.02
EBIT, 2 Yr. CAGR %	47.82	13.17	8.61	29.77	60.99
Earnings From Cont. Operations, 2 Yr. CAGR %	87.57	-53.38	205.39	592.62	-70.01
Net Income, 2 Yr. CAGR %	93.16	-52.81	206.89	584.49	-63.85
Normalized Net Income, 2 Yr. CAGR %	74.55	-34.84	182.57	357.54	-27.18
Diluted EPS Before Extra, 2 Yr. CAGR %	93.25	-52.86	206.86	584.63	-68.1
Accounts Receivable, 2 Yr. CAGR %	17.57	5.05	28	37.92	54.44
Inventory, 2 Yr. CAGR %	73.72	46.05	45.61	25.49	10.06
Net Property, Plant and Equip., 2 Yr. CAGR %	121.3	167.69	154.97	52.84	5.81
Total Assets, 2 Yr. CAGR %	91.72	77.41	75.93	43.23	11.62
Tangible Book Value, 2 Yr. CAGR %	39.43	40.79	44.15	46.08	42.63
Common Equity, 2 Yr. CAGR %	37.72	40.62	47.88	43.05	36.5
Cash From Operations, 2 Yr. CAGR %	455.47	386.14	-41.31	-35.09	-35.92
Capital Expenditures, 2 Yr. CAGR %	274.02	245.15	-4.53	-52.37	35.84
Levered Free Cash Flow, 2 Yr. CAGR %	151.96	170.75	-40.69	-58.71	68.81
Unlevered Free Cash Flow, 2 Yr. CAGR %	176.39	195.76	-4.2	-65.54	152.24
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	81.15	51.58	61.12	41.55	30.12
Gross Profit, 3 Yr. CAGR %	59.65	50.98	64.69	73.6	42.38
EBITDA, 3 Yr. CAGR %	113.72	38.61	35.6	52.31	42.01
EBITA, 3 Yr. CAGR %	131.46	39.31	30.41	48.32	42.99
EBIT, 3 Yr. CAGR %	137.74	41.05	31.53	51.33	47.91
Earnings From Cont. Operations, 3 Yr. CAGR %	20.25	-2.31	146.05	172.9	62.74
Net Income, 3 Yr. CAGR %	21.27	1.02	145.43	174.56	82.39
Normalized Net Income, 3 Yr. CAGR %	27.78	30.17	107.23	188.87	119.45
Diluted EPS Before Extra, 3 Yr. CAGR %	21.22	1.01	145.42	174.54	67.81
Accounts Receivable, 3 Yr. CAGR %	49.84	23	37.79	59.97	58.13
Inventory, 3 Yr. CAGR %	67.33	59.85	86.71	50.48	37.24
Net Property, Plant and Equip., 3 Yr. CAGR %	138.13	137.41	221.43	116.9	53.67
Total Assets, 3 Yr. CAGR %	83.45	79.93	128.78	73.23	49.1
Tangible Book Value, 3 Yr. CAGR %	50.62	54.38	61.85	86.21	44.9
Common Equity, 3 Yr. CAGR %	48.48	53.48	64.1	84.06	42.8
Cash From Operations, 3 Yr. CAGR %	173.68	228.39	139.97	-8.22	-48.1
Capital Expenditures, 3 Yr. CAGR %	179.03	160.43	155.86	-22.92	21.96
Levered Free Cash Flow, 3 Yr. CAGR %	59.02	202.22	24.97	-8.13	16.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	53.77	236.53	80.34	-17.32	12.43
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	80.97	63.28	69.43	76.87	68.5
Gross Profit, 5 Yr. CAGR %	60.92	62.4	74.98	81.16	76.76
EBITDA, 5 Yr. CAGR %	58.7	68.12	90.82	70.97	66.44
EBITA, 5 Yr. CAGR %	57.56	69.94	95.13	69.78	65.77
EBIT, 5 Yr. CAGR %	57.56	72.31	98.3	71.06	66.62
Earnings From Cont. Operations, 5 Yr. CAGR %	44.7	26.75	99.48	168.4	23.88
Net Income, 5 Yr. CAGR %	44.22	27.39	100.89	172.56	33.29
Normalized Net Income, 5 Yr. CAGR %	35.11	36.67	99.57	168.51	68.45
Diluted EPS Before Extra, 5 Yr. CAGR %	16.05	19.76	100.86	172.65	26.78
Accounts Receivable, 5 Yr. CAGR %	48.56	47.79	60.76	61.61	68.51
Inventory, 5 Yr. CAGR %	82.33	61.19	80.86	82.11	76.59
Net Property, Plant and Equip., 5 Yr. CAGR %	167.43	140.67	179.64	149.84	140.8
Total Assets, 5 Yr. CAGR %	97.22	73.67	106.14	106.13	100.61
Tangible Book Value, 5 Yr. CAGR %	109.18	52.01	69.11	89.52	79.78
Common Equity, 5 Yr. CAGR %	103.92	51.76	69.38	87.28	78.12
Cash From Operations, 5 Yr. CAGR %	299.46	228.66	68.93	115.49	59.4
Capital Expenditures, 5 Yr. CAGR %	245	144.41	107.61	65.66	132.07
Levered Free Cash Flow, 5 Yr. CAGR %	129.7	126.64	36.01	74.54	109.07
Unlevered Free Cash Flow, 5 Yr. CAGR %	175.49	136.96	64.82	73.53	112.38